![William Sandborn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
William Sandborn
Direktor/Vorstandsmitglied bei
Prometheus Laboratories, Inc.
Profil
William J.
Sandborn is the founder of Shoreline Biosciences, Inc. Current jobs include Director at Prometheus Laboratories, Inc., Chief-Gastroenterology & Professor-Clinical Medic at the University of California San Diego since 2011, and Advisor at Forbion Capital Partners Management Holding BV.
Former jobs include Director at Prometheus Biosciences, Inc. and President & Chief Medical Officer at Ventyx Biosciences, Inc. from 2022 to 2023.
Education includes a doctorate from Loma Linda University conferred in 1987 and an undergraduate degree from Southern University College.
Aktive Positionen von William Sandborn
| Unternehmen | Position | Beginn |
|---|---|---|
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.01.2011 |
Prometheus Laboratories, Inc.
 Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel pharmaceutical and diagnostic products | Direktor/Vorstandsmitglied | - |
Forbion Capital Partners Management Holding BV
 Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion is an active manager invest companies located in Northwest Europe and the United States. The firm focuses on companies operating in the fields of life sciences and biomedical technology. It participates in early stage capital requirements with an investment size ranging from EUR 1 - 7 million. It participates in follow-on investments, takes a board seat and acts as lead investor. | Berater | - |
Ehemalige bekannte Positionen von William Sandborn
| Unternehmen | Position | Ende |
|---|---|---|
| VENTYX BIOSCIENCES, INC. | Präsident | 22.11.2023 |
| PROMETHEUS BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 04.02.2021 |
Shoreline Biosciences, Inc.
 Shoreline Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Gründer | - |
Ausbildung von William Sandborn
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
88
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Loma Linda University
 Loma Linda University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel pharmaceutical and diagnostic products | Health Technology |
Forbion Capital Partners Management Holding BV
Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion is an active manager invest companies located in Northwest Europe and the United States. The firm focuses on companies operating in the fields of life sciences and biomedical technology. It participates in early stage capital requirements with an investment size ranging from EUR 1 - 7 million. It participates in follow-on investments, takes a board seat and acts as lead investor. | Finance |
Southern University College
 Southern University College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prometheus Biosciences, Inc.
 Prometheus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops medicines for immune-mediated diseases | Health Technology |
Ventyx Biosciences, Inc.
 Ventyx Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapies for patients with autoimmune, inflammatory and neurodegenerative diseases | Health Technology |
Shoreline Biosciences, Inc.
Shoreline Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
